Molecular determinants of topoisomerase I poisoning by lamellarins: Comparison with camptothecin and structure-activity relationships

被引:206
作者
Marco, E
Laine, W
Tardy, C
Lansiaux, A
Iwao, M
Ishibashi, F
Bailly, C
Gago, F
机构
[1] Ctr Oscar Lambret, IRCL, INSERM, U 524, F-59045 Lille, France
[2] Ctr Oscar Lambret, IRCL, Lab Pharmacol Antitumorale, F-59045 Lille, France
[3] Univ Alcala de Henares, Dept Farmacol, E-28871 Alcala De Henares, Spain
[4] Nagasaki Univ, Fac Engn, Nagasaki 8528521, Japan
[5] Nagasaki Univ, Fac Fisheries, Nagasaki 8528521, Japan
关键词
D O I
10.1021/jm049060w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of lamellarin derivatives have been studied as topoisomerase I (Top1) inhibitors. Molecular models of the ternary complexes formed between the DNA-Top1 ensemble and lamellarin D (LMD) or camptothecin (CPT) fully intercalated into the duplex DNA have been built and studied by means of nanosecond molecular dynamics simulations in aqueous solution. Our results show that the 20-OH and 8-OH of LMD can participate in hydrogen-bonding interactions with the side chains of Glu356 and Asn722, respectively, the latter being consistent with the finding that CEM/C2 cells, which are resistant to CPT, are cross-resistant to LMD. Our models also account for the observation that LMD stabilizes Top1 cleavage at CG sites in addition to the TG sites observed for CPT and rationalize the structure-activity relationships within the series. The deleterious effect of replacing the 20-OH in LMD with a hydrogen was confirmed using a set of thermodynamic integration free energy simulations.
引用
收藏
页码:3796 / 3807
页数:12
相关论文
共 47 条
[1]   METABOLITIES OF THE MARINE PROSOBRANCH MOLLUSK LAMELLARIA SP [J].
ANDERSEN, RJ ;
FAULKNER, DJ ;
HE, CH ;
VANDUYNE, GD ;
CLARDY, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (19) :5492-5495
[2]  
AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009
[3]   Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks [J].
Bailly, C ;
Lansiaux, A ;
Dassonneville, L ;
Demarquay, D ;
Coulomb, H ;
Huchet, M ;
Lavergne, O ;
Bigg, DCH .
BIOCHEMISTRY, 1999, 38 (47) :15556-15563
[4]  
Bailly C, 2001, METHOD ENZYMOL, V340, P610
[5]   Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs [J].
Bailly, C .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 45 (01) :91-108
[6]  
Bailly Christian, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P363, DOI 10.2174/1568011043352939
[7]   NUCLEOTIDE-SEQUENCE PREFERENCE AT RAT-LIVER AND WHEAT-GERM TYPE-1 DNA TOPOISOMERASE BREAKAGE SITES IN DUPLEX SV40 DNA [J].
BEEN, MD ;
BURGESS, RR ;
CHAMPOUX, JJ .
NUCLEIC ACIDS RESEARCH, 1984, 12 (07) :3097-3114
[8]   PREFERENTIAL BINDING OF THE CARBOXYLATE FORM OF CAMPTOTHECIN BY HUMAN SERUM-ALBUMIN [J].
BURKE, TG ;
MI, ZH .
ANALYTICAL BIOCHEMISTRY, 1993, 212 (01) :285-287
[9]  
Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007
[10]   APPLICATION OF THE MULTIMOLECULE AND MULTICONFORMATIONAL RESP METHODOLOGY TO BIOPOLYMERS - CHARGE DERIVATION FOR DNA, RNA, AND PROTEINS [J].
CIEPLAK, P ;
CORNELL, WD ;
BAYLY, C ;
KOLLMAN, PA .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1995, 16 (11) :1357-1377